Author

Angelica Frusteri Chiacchiera

Institut national de recherche en sciences et technologies du numériqueORCID 0000-0003-2526-139XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Synthetic Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1

Frequent Co-Authors

Lorenzo PasottiiD· 2 shared Massimo BellatoiD· 2 shared Michela CasanovaiD· 2 shared Paolo MagniiD· 2 shared Aurora PiazzaiD· 1 shared Davide De MarchiiD· 1 shared Elia SalibiiD· 1 shared Grégory BattiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Lorenzo PasottiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synthetic BiologyScientific ReportsPeer-reviewedJan 2, 2025

Harnessing CRISPR interference to re-sensitize laboratory strains and clinical isolates to last resort antibiotics

Angelica Frusteri Chiacchiera, Michela Casanova, Massimo Bellato…·Lorenzo Pasotti

This study uses CRISPR interference to reduce antibiotic resistance in E. coli by targeting resistance genes without causing mutations.

21 citationstop 2%

E. coliexperimental assay

𝕏 PostBluesky

Synthetic BiologyFrontiers in Bioengineering and BiotechnologyPeer-reviewedJan 28, 2022

CRISPR interference as low burden logic inverters in synthetic circuits: characterization and tuning

Massimo Bellato, Angelica Frusteri Chiacchiera, Elia Salibi…·Lorenzo Pasotti

This paper evaluates CRISPR interference as low burden logic inverters in synthetic circuits, demonstrating reduced metabolic load through in-vivo assays.

14 citations

experimental assay

𝕏 PostBluesky